Literature DB >> 12733132

Incidence of ovarian cancer by race and ethnicity in the United States, 1992-1997.

Marc T Goodman1, Holly L Howe, Ko Hui Tung, Joellyn Hotes, Barry A Miller, Steven S Coughlin, Vivien W Chen.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12733132     DOI： 10.1002/cncr.11349

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  29 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  Introduction to the special issue on gene-hormone interplay.

Authors:  K Paige Harden; Kelly L Klump
Journal:  Behav Genet       Date:  2015-04-23       Impact factor: 2.805

3.  Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysis.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Rayna K Matsuno; Michael E Carney; Marc T Goodman
Journal:  Gynecol Oncol       Date:  2010-06-29       Impact factor: 5.482

4.  EpCAM-autoantibody levels in the course of disease of ovarian cancer patients.

Authors:  Martin Heubner; Dino Errico; Sabine Kasimir-Bauer; Dorothee Herlyn; Rainer Kimmig; Pauline Wimberger
Journal:  Med Oncol       Date:  2010-04-10       Impact factor: 3.064

5.  Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.

Authors:  Christina Blassl; Jan Dominik Kuhlmann; Alessandra Webers; Pauline Wimberger; Tanja Fehm; Hans Neubauer
Journal:  Mol Oncol       Date:  2016-04-20       Impact factor: 6.603

6.  Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.

Authors:  Kosuke Yoshihara; Atsushi Tajima; Tetsuro Yahata; Shoji Kodama; Hiroyuki Fujiwara; Mitsuaki Suzuki; Yoshitaka Onishi; Masayuki Hatae; Kazunobu Sueyoshi; Hisaya Fujiwara; Yoshiki Kudo; Kohei Kotera; Hideaki Masuzaki; Hironori Tashiro; Hidetaka Katabuchi; Ituro Inoue; Kenichi Tanaka
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

7.  Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer.

Authors:  Karen Stammer; Seby L Edassery; Animesh Barua; Pincas Bitterman; Janice M Bahr; Dale Buchanan Hales; Judith L Luborsky
Journal:  Gynecol Oncol       Date:  2008-02-13       Impact factor: 5.482

8.  Population pharmacokinetics and dosing recommendations for cisplatin during intraperitoneal peroperative administration: development of a limited sampling strategy for toxicity risk assessment.

Authors:  Bernard Royer; Vincent Jullien; Emmanuel Guardiola; Bruno Heyd; Bruno Chauffert; Jean-Pierre Kantelip; Xavier Pivot
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

9.  Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials.

Authors:  John H Farley; Chunqiao Tian; G Scott Rose; Carol L Brown; Michael Birrer; G Larry Maxwell
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

10.  Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact?

Authors:  Marc T Goodman; Yurii B Shvetsov
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.